Norastemizole. Antihistamine

Drugs of the Future

Volumn 23, Issue 9, 1998, Pages 966-969

  Handley, D A ^a   Hong, Y ^a   Bakale, R ^a   Senanayake, C ^a  

^a SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; LORATADINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NORASTEMIZOLE; TERFENADINE;

ALLERGIC DISEASE; AREA UNDER THE CURVE; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; DIARRHEA; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; NONHUMAN; TORSADE DES POINTES; URTICARIA; VOMITING;

EID: 0032449220     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.09.468507     Document Type: Article

References (22)